Nisha Almeida is a Research Scientist at the Technology Assessment Unit of the McGill University Health Centre. She has a BSc in Molecular Biology and a PhD in Epidemiology and Biostatistics from McGill University. Her doctoral research focused on the patterns and consequences of prenatal antidepressant use among women with chronic conditions, during which she honed her abilities to work with large administrative health databases. Nisha has also researched novel techniques of quantifying maternal active and passive exposure to tobacco smoke. She is particularly interested in harnessing hospital data to improve health outcomes and services.
Marie Belmonte joined the Technology Assessment Unit on October 1, 2018. She is an administrative technician with the Technology Assessment Unit at the McGill University Health Centre. She holds a Bachelor of Commerce degree in marketing from Concordia University. She has strong organizational and analytical skills.
James Brophy is the Chair of the Policy Committee of the Technology Assessment Unit of the McGill University Health Centre. He is a practicing cardiologist with a Ph.D. in Epidemiology and Biostatistics. He is a funded scholar from the Fonds de Recherche du Quebec (Santé) with a chair in health technology assessment and evidence-based medicine. His research interests center on cardiovascular epidemiology with a special interest in pharmacoepidemiology, outcomes research, medical decision making as well as health technology assessments, including economic analyses. He has published over 150 peer-reviewed articles. He is a full professor in the departments of medicine and epidemiology and biostatistics at McGill University.
Nandini Dendukuri is the Director of the Technology Assessment Unit of the McGill University Health Centre. She is also an Associate Professor at the Department of Medicine, McGill University, Montreal. Her research program in the area of developing Bayesian statistical methods for health technology assessment of diagnostic studies is supported by grants from the Canadian Institutes of Health Research (CIHR) and Natural Sciences and Engineering Research Council of Canada (NSERC).
Felipe Forero is a Research Scientist at the Technology Assessment Unit of the McGill University Health Centre. He holds a degree in Medicine from Columbia, an MSc in Health Economics from the University Pompeu Fabra of Barcelona and an MSc in Health Technology Assessment from the University of Montreal. His main interests include Economic evaluation of drugs and medical devices, disease modeling, Budget Impact Analysis (BIA), systematic literature review, and rapid health technology assessment.
Alain Lapointe is a visiting consultant at the MUHC's Technology Evaluation Unit. He joined the CHUM/MUHC Technology Assessment Unit in November 2006 and was an affiliated member until his retirement. He holds a master's degree in mechanical engineering from École Polytechnique de Montréal, a master's degree in health administration from the University de Montréal, a medical faculty and a doctorate in applied sciences (biomedical engineering) at the École Polytechnique de Montréal. He completed his postdoctoral studies at Hôpital Sacré-Coeur and joined the research team (a division of cardiology) at the Hôtel-Dieu Hospital (CHUM). In 1981, Alain founded the biomedical engineering department of the Hôtel-Dieu Hospital. After completing his master's degree in health administration in 1996, he served as president of the Association of Biomedical Physicians and Engineers of Quebec for a period of four years. In 1997, he led the new physical and biomedical engineering group at the CHUM (University of Montreal Hospital Centre). In 2001, he became Director of Health Technology Planning at the CHUM Implementation Corporation (SICHUM) and in October 2002, Alain joined the management team of the Technology Resources Group (CHUM). He was a director of the Office of Project Management.